Advanced search
Publication Cover
Audiology Volume 27, 1988 - Issue 4
Journal homepage
22
Views
20
CrossRef citations to date
0
Altmetric
Original Article

Hearing Loss and Desferrioxamine in Homozygous Beta-Thalassemia

R. Albera ENT Department, University of Turin, Italy
,
F. Pia ENT Department, University of Turin, Italy
,
B. Morra ENT Department, University of Turin, Italy
,
M. Lacilla ENT Department, University of Turin, Italy
,
L. Bianco Department of Pediatrics, University of Turin, Italy
,
V. Gabutti Department of Pediatrics, University of Turin, Italy
&
A. Piga Department of Pediatrics, University of Turin, Italy
 show all
Pages 207-214 | Received 18 Feb 1987, Accepted 12 Feb 1988, Published online: 07 Jul 2009

References

  • Arden G. B., Wonke B., Kennedy C, Huens E. R. Ocular changes in patients undergoing long term desferrioxamine treatment. Br. J. Ophthal. 1984; 68: 873–877
  • Davies S. C., Marcus R. E., Hungerford J. L., Miller M. H., Arden G. B., Huens E. R. Ocular toxicity of high dose intravenous desferrioxamine. Lancet 1983; ii: 181–184
  • De Virgiilis S., Argiolu R, Sanna G., Cornacchia G., Cossu P., Cao A., Mallardi V., Puxeddu P. Auditory involvement in thalassemia major. Acta hae-mat. 1979; 61: 209–215
  • Fiellau-Nikolajsen M. Epidemiology of secretory otitis media.A descriptive cohort study. Ann Otol. Rhinol. Lar. 1983; 92: 172–177
  • Hazell J. V.P., Modell C. B. ENT complications in thalassemia major. J. Lar. Otol. 1976; 90: 877–881
  • Lakhanpal V., Schocket S. S., Jiji R. Desferrioxamine induced toxic retinal pigmentary degeneration and pressumed optic neuropathy. Ophtalmology 1984; 91: 443–451
  • Lederman H. M., Cohen A., Lee J. W.W., Freedman M. H., Gelfand E. W. Desferrioxamine: a reversible S-phase inhibitor of human lymphocyte proliferation. Blood 1984; 64: 748–753
  • Logothetis J., Constantoulakis M., Economidou J., Stefanis C, Hakas P., Augoustaki O., Sofroniadou K., Loewenson R., Bilek M. Thalassemia major.A survey of 138 cases with emphasis on neurologic and muscular ascpects. Neurology 1972; 22: 294–304
  • Modell B., Berdoukas V. The clinical approach to thalassemia. Grune & Stratton, New York 1984
  • Mosciaro D., Borgatti L. La funzione uditiva nel morbo di Cooley. Atti Giornate di Studio Microcitemia, Ferrara 1965; vol. 1: 184–186
  • Olivieri N. F., Buncic R. J., Chew E., Gallant T, Harrisin R. V., Keenan N. B.A., Logan W., Mitchell D., Ricci G., Skarf B., Taylor M., Freedman M. H. Visual and auditory neurotoxicity in patients receiving subcutaneous deferoxamine infusions. New Engl. J. Med. 1986; 314: 869–873
  • Simon P., Ang K. S., Meyrier A., Allain P., Mauras Y. Desferrioxamine, ocular toxicity, and trace metals. Lancet 1983; 2: 817–818
  • Weatherall D. J., Clegg J. B. The thalassemia syndromes. Blackwell, Oxford 1981

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.